| Followers | 167 |
| Posts | 42768 |
| Boards Moderated | 3 |
| Alias Born | 10/20/2019 |
Wednesday, July 21, 2021 2:40:09 PM
It's an interesting new technology...$RMTI
In addition, FPC iron is delivered regardless of other underlying conditions which might otherwise block the release of iron. Some of the challenges of managing iron in sick patients, including inflammation, hepcidin block, and functional iron deficiency, can be overcome with FPC due to its ability to provide bioavailable iron.
FPC is highly soluble in water and, therefore, can be formulated for parenteral administration either by the dialysis solution or intravenously. As a result, this novel approach to iron management has the potential for application in the treatment of anemia in many disease states.
In addition, FPC iron is delivered regardless of other underlying conditions which might otherwise block the release of iron. Some of the challenges of managing iron in sick patients, including inflammation, hepcidin block, and functional iron deficiency, can be overcome with FPC due to its ability to provide bioavailable iron.
FPC is highly soluble in water and, therefore, can be formulated for parenteral administration either by the dialysis solution or intravenously. As a result, this novel approach to iron management has the potential for application in the treatment of anemia in many disease states.
Recent RMTI News
- Rockwell Medical Renews Product Purchase Agreement with aQua Dialysis • Business Wire • 05/20/2026 10:00:00 AM
- Rockwell Medical Signs New 3-Year Product Purchase Agreement with Heritage Dialysis • Business Wire • 05/14/2026 10:00:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/11/2026 08:16:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2026 09:00:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 11:14:09 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 10:59:14 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 10:16:19 AM
- Rockwell Medical Announces First Quarter 2026 Results and Additional 2026 Guidance with Focus on Profitability • Business Wire • 05/07/2026 10:00:00 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/30/2026 01:00:09 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/30/2026 10:59:07 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/20/2026 08:09:05 PM
- Rockwell Medical to Release First Quarter 2026 Results on Thursday, May 7, 2026 • Business Wire • 04/09/2026 10:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 11:30:28 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 11:01:16 AM
- Rockwell Medical tops earnings forecasts but shares slip on revenue decline • IH Market News • 03/26/2026 10:50:34 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 10:10:47 AM
- Rockwell Medical Announces Fourth Quarter and Full-Year 2025 Financial and Operational Results • Business Wire • 03/26/2026 10:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/16/2026 10:11:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/16/2026 10:10:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/16/2026 10:10:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/16/2026 10:09:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/16/2026 10:08:43 PM
